Effects of alosetron on spontaneous migrating motor complexes in murine small and large bowel in vitro (Q43737841)

26 November 2017

Effects of alosetron on spontaneous migrating motor complexes in murine small and large bowel in vitro (English)

1 reference

26 November 2017

1 reference

4

Sanders KM

0 references

Terence K. Smith

5

object named as

Smith TK

0 references

author name string

Bush TG

1

1 reference

26 November 2017

Spencer NJ

2

1 reference

26 November 2017

Watters N

3

1 reference

26 November 2017

1 October 2001

1 reference

American Journal of Physiology - Gastrointestinal and Liver Physiology

26 November 2017

1 reference

26 November 2017

281

1 reference

26 November 2017

4

1 reference

26 November 2017

G974-83

1 reference

Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study

26 November 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

Pharmacological differences and similarities between the native mouse 5-HT3 receptor in N1E-115 cells and a cloned short splice variant of the mouse 5-HT3 receptor expressed in HEK 293 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

Spontaneous migrating motor complexes occur in both the terminal ileum and colon of the C57BL/6 mouse in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

The pharmacological characterization of 5-HT3 receptors in three isolated preparations derived from guinea-pig tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

Pharmacological properties of GR38032F, a novel antagonist at 5-HT3 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

Review article: irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

Improvement in pain and bowel function in female irritable bowel patients with alosetron, a 5-HT3 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

The pharmacological properties of the novel selective 5-HT3 receptor antagonist, alosetron, and its effects on normal and perturbed small intestinal transit in the fasted rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

Anxiolytic potential of 5-HT3 receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

Effect of alosetron on responses to colonic distension in patients with irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

Review article: an integrated approach to the irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

Irritable bowel syndrome in office-based practice in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

Colonic migrating motor complexes (CMMCs) in the isolated mouse colon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

Modulation by 5-HT3 and 5-HT4 receptors of the release of 5-hydroxytryptamine from the guinea-pig small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. A comparison of their pharmacology and clinical efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

Review article: clinical pharmacology of alosetron

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

The potential anxiolytic activity of GR38032F, a 5-HT3-receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

Dysmotility of the small intestine in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

The properties of 5-HT3 receptors in clonal cell lines studied by patch-clamp techniques

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

Towards positive diagnosis of the irritable bowel

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

Review article: gender-related differences in functional gastrointestinal disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

Role of visceral afferent mechanisms in functional bowel disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

Medium-term effects of a new 5HT3 antagonist, alosetron, in patients with carcinoid diarrhoea

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

GR 38032F (ondansetron), a selective 5HT3 receptor antagonist, slows colonic transit in healthy man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

Irritable bowel syndrome defined by factor analysis. Gender and race comparisons

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

5-HT3 receptors mediate rapid responses in cultured hippocampus and a clonal cell line.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPGI.2001.281.4.G974

10.1152/AJPGI.2001.281.4.G974

21 January 2018

Identifiers

DOI

0 references

1 reference